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ABSTRACT 
More than 90 million people were currently infected with lymphatic filariasis and two-third of them 
lived in China, India and Indonesia. Filariasis is endemic throughout the entire Indonesian Archipelago. 
More than 20 million people lived in endemic m a s  and 3-4 million people were estimated to have the 
infection. Control measures have reduced the prevalence of infections in some mas,  but the disease 
remained a public health problem in many outer islands of Indonesia. Recent development in monoclonal 
antibodies and recombinant technology of DNA have made it possible to apply these new tools in the 
studies of filariasis, and three groups in Indonesia are currently using these new technology. The studies 
with the Imperial College of London will be presented by Dr. Rick Maizels. Collaboration with the New 
England Biolabs and Smith College involve the use of a stage and species-specific monoclonal antibody 
against the infective larvae of Brugia malayi, a double blind comparison of conventional methods and 
DNA probes for the diagnosis of brugian filariasis, and phylogentic studies of the brugian parasites. The 
ELISA using the monoclonal antibody has been adapted for field use in Jakarta. It is simple to use, does 
not cross-react with the infective stage of Brugia pahungi, but does so with the infective stage of the 
non-sympatric Brugia timori. The reagent is useful to acurately monitor the progress of control programs 
in endemic m a s  of brugian filariasis. The oligonucleotide DNA probes for B.malayi and B.pahangi were 
both qualitatively and quantitatively comparable to the conventional methods for the diagnosis of brugian 
parasites in cats and man. Sequencing data of the repeated DNA sequences of various brugian parasites 
indicated their homologies and divergences. The anthropophilic strain of B.malayi and B.timori showed 
similarity in their biological characteristics and repeated DNA sequences and they are phylogenically 
probably closely related. One isolate of B.malayi from Tanjung Pinang showed closer homology to the 
repeated DNA sequences of B.pahungi than to that of B.malayi. Studies on the repeated DNA sequences 
of different isolates of brugian parasites are essential before DNA probes can be widely used in field 
studies. 
INTRODUCTION (WHO Expert Committee Meeting, Geneva, 
1983). Filariasis is endemic throughout the 
Lymphatic filariasis remains a public Indonesian Archipelago. More than 20 mil- 
health problem in many parts of the world. lion people are at risk of acquiring the infec- 
According to a recent WHO estimate, more tion, and 3-4 million people were estimated 
than 90 million people were currently in- to be infected. Control measures have 
fected with the parasites, and two-third of reduced the prevalence of infection in some 
them lived in China, India and Indonesia economic development areas, but the disease 
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remains a public health problem in many 
outer islands of Indonesia. Recent advances 
in immunology and recombinant DNA tech- 
nology have made it possible to apply these 
new tools in the studies of filariasis. Several 
groups are currently involved in biotechno- 
logy research in Indonesia and three are 
working on filariasis: Dr. Kurniawan's, Dr. 
Nurhajati's and our group. Our project is a 
collaborative research effort involving the 
laboratories of Dr. Rick Maize1 of Imperial 
College, London, Dr. Steven Williams of 
Smith College, USA, Drs. Larry Mc Rey- 
nolds, Mario Philipp and Clotilde Carlow of 
New England Biolabs, USA, and the Depart- 
ment of Parasitology, Faculty of Medicine, 
University of Indonesia. 
IMMUNOLOGICAL STUDIES 
A range of surface, secreted and somatic 
antigens from filarial parasites have been 
studied in order to analyse the response of 
humans infected with these parasites, and to 
develop reliable diagnostic and prophylactic 
agents. Diagnostic procedures are being 
developed by two techniques. Firstly, detec- 
tion of host antibody is carried out using 
selected specific parasite antigens in the form 
of recombinant peptides from a filarial DNA 
library. Secondly, measurement of parasite 
antigen released into host serum during infec- 
tion is performed by an ELISA antigen cap- 
ture assay, using a monoclonal antibody 
(Table 1). In addition, a longer term objective 
is to isolate molecules which may stimulate 
protective immune responses against filarial 
parasites. A major focus has been a parasite 
surface glycoprotein known to be closely 
conserved between adult worms of Brugia 
malayi, Brugia timori and Wuchereria 
bancrofti. The antigen has been cloned from 
a cDNA library, and its primary sequence 
established. In addition to being a constant 
feature of the adult surface, it is expressed by 
developing larvae and represents an attractive 
target for vaccine production. Finally, we are 
trying to dissect the genesis of pathological 
reactions, by comparing the immune respon- 
ses of individuals of differing clinical status 
to certain defined parasite antigens in an at- 
tempt to correlate disease development with 
particular categories of immune response in 
infected patients. 
FIELD TESTIN(; OF FIIJAIllAI~ 
SPECIFIC DNA PROBES 
A DNA probe to detect Brugian para- 
sites has been developed by the New England 
~iolabs' .  Based upon the region of diver- 
gence of the Hha I repeat of B.malayi (Bm) 
and B.pahangi (Bp), a 29-mer Bm specific 
and a 21-mer Bp specific oligonucleotide 
probes were developed2 (Table 2). These 
probes were radiolabeled with P32 and used 
in a dot blot assay to detect brugian micro- 
filariae from donors in South Kalimantan, 
where Bp had been reported to occur in 
3 humans . The tests were blindly performed 
using Bm and Bp from experimentally in- 
fected animals as controls, and the results 
compared with those obtained by para- 
sitological examination of microfilariae. Two 
hundred human blood samples were tested by 
both methods, and the agreement was 97 % 
(Table 3). An additional 64 cat blood samples 
were also blindly tested by both methods and 
the agreement was 95 % (Table 4). The den- 
sities of microfilariae (Mf) in these samples 
were stratified into different levels, ranging 
from 0-49 to over 1000 per unit of blood. The 
degrees of agreement by both methods ranged 
from 0-100%, averaging 82 % (Table 5). 
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PRELIMINARY FIELD TESTING 
T O  NONRADIOACTIVE DNA 
PROBES 
A variety of non-radioactive DNA 
probes have been constructed and tested 
under laboratory conditions. Most of the ef- 
fort was concentrated on the development of 
biotinylated oligonucleotide probes. The ini- 
tial radio-labeled Bm specific 29-mer 
oligonucleotide and the Bp specific 21-mer 
oligonucleotide DNA probes were able to 
detect as little as 0.1 ng of Brugia DNA (ap- 
proximately equal to 1 mf) and are species- 
specific. When these probes were labeled 
with six biotin residues attached via uridine 
nucleotides to the 5' end, the sensitivity was 
reduced to about 1-2 ng. To improve the sen- 
sitivity, two new oligonucleotide probes were 
synthesized based upon the Hha I repeat 
region of divergence: a 45-mer Bm-specific 
and a 44-mer Bp-specific DNA probe, They 
were labeled with 45 biotinylated uridine 
residues added to the 5' end. The biotinylated 
uridine residues were alternated in the chain 
with non-biotinylated thymidine residues, 
which served as spacers between the biotiny- 
lated uridine residues, and allow for more 
efficient binding of the biotin moieties by the 
avidin or streptavidin detector molecules. 
Thus, these new probes are 135 and 134 
nucleotides in length. The sensitivity of 
detection of these probes was in the range of 
0.1 ng and each probe still retained its species 
specificity. 
The new probes were field tested on 43 
human and 14 cat blood samples, collected 
from microfilaraemic donors on the island of 
Rampang, near Tanjung Pinang. A part of 
each sample was amplified by the polymerase 
chain reaction (PCR) and compared with the 
unamplified samples using both radioactive 
and biotinylated DNA probes. All the results 
were subsequently compared with the con- 
ventional detection system of microfilariae. 
The PCR amplified samples were accurately 
identified by both the radioactive and biotiny- 
lated probes. The samples that were not PCR 
amplified were accurately identified only 
after long exposures (more than one week) by 
the radioactive probes. The biotinylated 
probes were not sensitive enough to accurate- 
ly identify the non PCR amplified samples. 
CLONING AND CHARACTERIZA- 
TION O F  THE Hha I REPEATS 
FROM BRUGIAN FILARIA 
Studies on the evolution of filarial para- 
sites in humans and animals were also done. 
Consensus sequences of the Hha I repeats of 
several isolates of brugian parasites have 
been determined by our group. The difference 
between the Hha I repeats of the zoophilic and 
the anthropophilic strain of B.malayi is small, 
and so is the difference between the repeats 
of B.malayi and B.timori. These data will be 
computer-analysed to determine whether it is 
possible to construct a strain-specific 
malayan or a timorian specific DNA probe. 
There is one strain of B.malayi that we 
have isolated from a cat from Tanjung 
Pinang, which hybridized in a unique way to 
the DNA probes. The microfilariae are iden- 
tified as B.malayi by morphological criteria 
(Purnomo, unpublished data) but the DNA of 
this isolate only hybridized to the Bp-specific 
DNA probe. Nine repeats of this parasite were 
sequenced in their entirety and the data com- 
puter-analysed. The analysis confirmed the 
results of the DNA hybridization studies, in- 
dicating similarity between the repeats of this 
isolate and that of B.pahangi. In order to 
investigate this problem further, a field trip to 
Tanjung Pinang was recently organized to 
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collect microfilariae from a number of in- 
fected humans and cats. These samples were 
currently being evaluated using our DNA 
probes and the polymerase chain reaction 
(PCR). 
FIELD TESTIN(; OF A STAGE AND 
SPECIES SPECIFIC MONOCLO- 
NAL ANTIBODY 
A stage and species specific monoclonal 
antibody to detect a unique surface epitope of 
B.malayi infective larvae has been developed 
by Mario Philipp's group at the New England 
~ i o l a b s ~ .  An ELISA field assay was sub- 
sequently developed to identify infective lar- 
vae of B.malayi in vector mosquitoes. The 
sensitivity of detection of this assay was in the 
range of 70 to 80% if the monoclonal an- 
tibody was incubated with the parasites for 1 
hour in our laboratory in Jakarta, slightly 
lower than that obtained at the base labo- 
ratory. However, by increasing the incubation 
time to two hours, the sensitivity was in- 
creased to more than 90 % . The monoclonal 
antibody did not cross-react with the infective 
larvae of B.pahangi, but did so with the non- 
sympatric L3s of B.timori. The reagent was 
field tested in South Kalimantan in an area 
endemic with B.malayi and enzootic with 
B.pahangi, where DEC control measures 
against brugian parasites in humans have 
been repeatedly applied. More than 3000 
potential vectors were dissected for filarial 
larvae. Only 131 infective larvae were 
recovered and of these only a small fraction 
of them (10) were identified as B.malayi 
(Table 6). This is a good example of how the 
use of modem technology can help endemic 
countries to cost-effectively control brugian 
filariasis. If the tool has not been made avail- 
able for field use, the infective rates in vector 
mosquitoes would have been incorrectly es- 
timated by a factor of more than 10 fold, 
which may probably result in a wrong 
decision making at the control level of 
filariasis, and consequently a waste in control 
efforts. 
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Table 1. Decreasing circulating antigen among villagers in Karakuak, Flores, after DEC treatments. 
Year Individuals tested Antigen-Positive Antigen-Negative 
-- pp - -
1982 130 21 (16.2%) 109 (83.8%) 
1988 130 2 ( 1.5%) 128 (98.5%) 
Circulating antigen levels were determined in a two-site ELISA using monoclonal antibody to the phosphoryl- 
choline epitope. The decrease in circulating 'antigen levels paralleled the decrease in microfilaria and disease rates. 
Table 2. Comparison between the repeated DNA sequences of B.malayi and B.pahangi 
B.malayi 
0 322 
93 % HOMOLOGY 72 % HOMOLOGY 
B.pahangi 
0 322 
B. malayi 29 mer probe 
A A G C T - T A T T T T G A A C C T A A T I ' G A C T A T G T I ' A C G T G C A ' I T G T A C C A G T G C T G  
209 
* = Mismatch 
275 
B .pahangi 2 1 mer probe 
Table 3. Detection of brugian mf in human blood 
No. B.malayi B.pahangi 
Tested *Par Probe Par Probe % Agree 
200 200 193 0 1 97 
20 Bp 0 0 20 20 100 
37 Bm 37 37 0 0 100 
* PAR = Parasitology 
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Table 4. Detection of microfilariae in cat blood 
No. B.nlalayi B.pahangi D.repens 
Tested *Par Probe Par Probe Par Probe % Agree 
* Par = Parasitology 
Table 5. Quantitative Determination of mf Densities 
Density 
Human blood Cat blood SK Cat blood Lab 
Par Probe % Par Probe % Par Probe % 
Total 200 200 42 42 57 57 
Par = Parasitology 
SK = South Kalimantan 
Lab = Laboratory 
Table 6. Identification of Bm L3 by Monoclonal Antibody 
Number of wild caught mosquitoes 
Number of mosquitoes dissected 
Number of infective larvae isolated 
Number of larvae identified by Mab 
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QUESTIONS AND ANSWERS : 
1. Question: The monoclonal antibody you use in detecting L3 is specific and highly sensitive. At this 
point, what further improvements and steps would you be taking before it could be 
implemented in a wider rangelother areas. 
Answer : It is ready for use for the filariasis control programme to accurately define the problem of 
Brugian filariasis, to monitor control efforts and to decide when to stop control measures. 
2. Question: - What is the origin of your cDNA library, (page 12). 
- Nucleic acid sequence of the T.Pinang strain showed several mismatches. How about the 
Amino Acid sequences ? 
Answer : - Any stage, but we use microfilariae. 
- No information on the amino acid sequences, because the repeats are a noncoding region. 
3. Question: Is the present knowledge enough to predict that B. pahangi would not infect man, since it 
has a distinct pathway. 
Answer : We cannot confirm the infection of B.pahangi in man in our recent studies. The evidence 
presented by Palmiery of B.pahangi infection in man is not tight. Biotechnology can 
certainly resolve this problem in the future. 
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